Preclinical safety studies of human embryonic stem cell‐derived retinal pigment epithelial cells for the treatment of age‐related macular degeneration

Preclinical safety studies of human embryonic stem cell‐derived retinal pigment epithelial cells for the treatment of age‐related macular degeneration

Abstract As pluripotent stem cell (PSC)‐based reparative cell therapies are reaching the bedside, there is a growing need for the standardization of studies concerning safety of the derived products. Clinical trials using these promising strategies are in development, and treatment for age‐related m...

Full description

Bibliographic Details
Main Authors: Sandra Petrus‐Reurer, Pankaj Kumar, Sara Padrell Sánchez, Monica Aronsson, Helder André, Hammurabi Bartuma, Alvaro Plaza Reyes, Emeline F. Nandrot, Anders Kvanta, Fredrik Lanner
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Stem Cells Translational Medicine
Subjects:
age‐related macular degeneration
biodistribution
cellular therapy
chemically defined
human embryonic stem cells
retinal pigment epithelium
Online Access:https://doi.org/10.1002/sctm.19-0396

Internet

https://doi.org/10.1002/sctm.19-0396

Similar Items